- Home
- SVRA vs ASPI Comparison
SVRA vs ASPI Comparison
Compare SVRA & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- ASPI
- Stock Information
- Founded
- SVRA 2007
- ASPI 2021
- Country
- SVRA United States
- ASPI United States
- Employees
- SVRA N/A
- ASPI N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- SVRA Health Care
- ASPI Industrials
- Exchange
- SVRA Nasdaq
- ASPI Nasdaq
- Market Cap
- SVRA 505.8M
- ASPI 470.6M
- IPO Year
- SVRA N/A
- ASPI 2022
- Fundamental
- Price
- SVRA $3.00
- ASPI $5.49
- Analyst Decision
- SVRA Buy
- ASPI Strong Buy
- Analyst Count
- SVRA 6
- ASPI 2
- Target Price
- SVRA $8.83
- ASPI $4.50
- AVG Volume (30 Days)
- SVRA 615.8K
- ASPI 1.9M
- Earning Date
- SVRA 05-16-2025
- ASPI 05-19-2025
- Dividend Yield
- SVRA N/A
- ASPI N/A
- EPS Growth
- SVRA N/A
- ASPI N/A
- EPS
- SVRA N/A
- ASPI N/A
- Revenue
- SVRA N/A
- ASPI $4,144,225.00
- Revenue This Year
- SVRA N/A
- ASPI $690.06
- Revenue Next Year
- SVRA N/A
- ASPI $93.09
- P/E Ratio
- SVRA N/A
- ASPI N/A
- Revenue Growth
- SVRA N/A
- ASPI 857.04
- 52 Week Low
- SVRA $2.26
- ASPI $1.86
- 52 Week High
- SVRA $5.31
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- SVRA 47.98
- ASPI 53.02
- Support Level
- SVRA $3.12
- ASPI $5.02
- Resistance Level
- SVRA $3.56
- ASPI $5.95
- Average True Range (ATR)
- SVRA 0.15
- ASPI 0.46
- MACD
- SVRA -0.01
- ASPI -0.03
- Stochastic Oscillator
- SVRA 21.19
- ASPI 47.00
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.